Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check7 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision metadata updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.4.2 was added to the history list. The notice about government funding operating status and the earlier revision v3.4.1 were removed.SummaryDifference0.3%

- Check78 days agoChange DetectedAdministrative updates were added to the history: a new notice about funding and a new version marker (v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check86 days agoChange DetectedThe history view now includes a Show glossary option and explanations for the color-coded changes (green = additions, red = deletions) and for data change color coding. Revision metadata now shows Revision: v3.4.0 and the No FEAR Act data label and the Revision: v3.3.4 text were removed.SummaryDifference0.3%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.